Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Immunity

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1074-7613(00)80295-2PMID 8574849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-level hepatitis B virus replication in transgenic mice

  1995cited by this paper
• Hepatitis B virus immunopathogenesis.

  1995cited by this paper
• Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes.

  1995cited by this paper
• Functional role of type I and type II interferons in antiviral defense.

  1994cited by this paper
• Expression of hepatic transcription factors during liver development and oval cell differentiation

  1994cited by this paper
• Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.

  1994cited by this paper
• Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice

  1994cited by this paper
• Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks

  1994cited by this paper
• Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte

  1994cited by this paper
• Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon

  1994cited by this paper
• Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

  1994cited by this paper
• Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways

  1994cited by this paper
• Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.

  1994cited by this paper
• Immune function in mice lacking the perforin gene.

  1994cited by this paper
• Phosphorylation of the duck hepatitis B virus capsid protein associated with conformational changes in the C terminus

  1994cited by this paper
• Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism

  1993cited by this paper
• Patterns of cytokine gene expression by CD4+ T cells from young and old mice.

  1993cited by this paper
• Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

  1993cited by this paper
• Cys residues of the hepatitis B virus capsid protein are not essential for the assembly of viral core particles but can influence their stability

  1992cited by this paper
• Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement

  1992cited by this paper
• Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice

  1992cited by this paper
• Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope.

  1992cited by this paper
• Liver regeneration: molecular mechanisms of growth control

  1990cited by this paper
• Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.

  1989cited by this paper
• Hepatic enzymic zonation: A reevaluation of the concept of the liver acinus

  1989cited by this paper
• Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.

  1989cited by this paper
• CTL: virus control cells first and cytolytic cells second? DNA fragmentation, apoptosis and the prelytic halt hypothesis.

  1989cited by this paper
• Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry.

  1988cited by this paper
• Recovery from Acute Virus Infection

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• The molecular biology of the hepatitis B viruses.

  1987cited by this paper
• Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.

  1986cited by this paper
• Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice

  1986cited by this paper
• Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice.

  1985cited by this paper
• Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.

  1985cited by this paper
• Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo

  1984cited by this paper

• AAV-HBV mouse model replicates the intrahepatic immune landscape of chronic HBV patients at single-cell level

  2025cites this paper
• Single‐Cell Profiling of Peripheral and Intrahepatic B Cells Reveals Altered Responses and a CCR7⁺ Subset Linked to Antiviral Potential in Chronic HBV Infection

  2025cites this paper
• Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases.

  2025cites this paper
• Chronic Hepatitis B Virus Persistence: Mechanisms and Insights

  2025cites this paper
• Antiviral and immune modulatory activities of STING agonists in a mouse model of persistent hepatitis B virus infection

  2025cites this paper
• Extrathymic CD8 and CD4 Double Positive T Cells Presenting Vigorous HBV‐Specific Responses Accelerate HBV Clearance

  2025influential citation
• Mathematical Models of Early Hepatitis B Virus Dynamics in Humanized Mice

  2024cites this paper
• CD40 stimulation activates CD8+ T cells and controls HBV in CD4-depleted mice

  2024cites this paper
• The frequency of hepatitis B virus reactivation in patients receiving anti-TNF treatment: a single center, retrospective study

  2024cites this paper
• The immune response in chronic HBV infection

  2024cites this paper
• Emerging Insights into Memory Natural Killer Cells and Clinical Applications.

  2024cites this paper
• Dynamics of a stochastic HBV infection model with general incidence rate, cell-to-cell transmission, immune response and Ornstein–Uhlenbeck process

  2024cites this paper
• Immune Response to Occult Hepatitis B Virus Infection Among Hemodialysis Patients: a review

  2024cites this paper
• A Dual‐domain Engineered Antibody for Efficient HBV Suppression and Immune Responses Restoration

  2024cites this paper
• Priming and Maintenance of Adaptive Immunity in the Liver.

  2024cites this paper
• Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection

  2024cites this paper
• Stability Analysis of Caputo Fractional Order Viral Dynamics of Hepatitis B Cellular Infection

  2023cites this paper
• TRAF2 as a key candidate gene in clinical hepatitis B-associated liver fibrosis

  2023cites this paper
• IFNγ is a central node of cancer immune equilibrium

  2023cites this paper
• Global dynamics of multiple delays within-host model for a hepatitis B virus infection of hepatocytes with immune response and drug therapy.

  2023cites this paper
• IFN-γ: A Crucial Player in the Fight Against HBV Infection?

  2023influential citation
• Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants

  2023cites this paper
• Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality

  2023cites this paper
• Stability and Hopf bifurcation on an immunity delayed HBV/HCV model with intra- and extra-hepatic coinfection and saturation incidence

  2023cites this paper
• CD8+ tissue-resident memory T cells induce oral lichen planus erosion via cytokine network

  2023cites this paper
• Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment

  2023cites this paper
• AAV-HBV mouse model replicates immune exhaustion patterns of chronic HBV patients at single-cell level

  2023cites this paper
• Dynamics of Hepatitis B Virus Covalently Closed Circular DNA: A Mini-Review

  2023cites this paper
• Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations

  2022cites this paper
• Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infection.

  2022cites this paper
• CD8+ tissue-resident memory T cells triggered the erosion of oral lichen planus by the cytokine network

  2022cites this paper
• Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B

  2022cites this paper
• Activities of endogenous APOBEC3s and uracil-DNA-glycosylase affect the hypermutation frequency of hepatitis B virus cccDNA.

  2022cites this paper
• Getting to HBV cure: The promising paths forward

  2022cites this paper
• Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System

  2022cites this paper
• Immune therapies against chronic hepatitis B

  2022cites this paper
• Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins

  2022cites this paper
• Focus on Dysregulated Adaptive Immunity in Chronic Hepatitis B: A Promising Direction for Immunotherapy

  2022cites this paper
• Increased HBV Coinfection and Decreased IFN-γ-Producing HBV-Specific CD8+ T Cell Numbers During HIV Disease Progression

  2022cites this paper
• Chimeric Virus-Like Particles of Prawn Nodavirus Displaying Hepatitis B Virus Immunodominant Region: Biophysical Properties and Cytokine Response

  2021cites this paper
• Significance of antiviral therapy and CTL-mediated immune response in containing hepatitis B and C virus infection

  2021cites this paper
• CD8 T cell-derived perforin and TNF-α are crucial mediators of neuronal destruction in experimental autoimmune enteric ganglionitis.

  2021cites this paper
• Animal Models of Hepatitis B Virus Infection–Success, Challenges, and Future Directions

  2021cites this paper
• Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIV

  2021influential citation
• Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability

  2021cites this paper
• The CD8+ T Cell Noncytotoxic Antiviral Responses

  2021cites this paper
• Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future

  2021cites this paper
• HBV-Specific CD8+ T-Cell Tolerance in the Liver

  2021cites this paper
• β-Catenin Signaling Regulates the In Vivo Distribution of Hepatitis B Virus Biosynthesis across the Liver Lobule

  2021cites this paper
• TNF Decoy Receptors Encoded by Poxviruses

  2021cites this paper
• A quantitative systems pharmacology model for acute viral hepatitis B

  2021cites this paper
• Persistent RNA virus infection is short-lived at the single-cell level but leaves transcriptomic footprints

  2021cites this paper
• Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm

  2021cites this paper
• Regulatory function of interferon‐inducible 44‐like for hepatitis B virus covalently closed circular DNA in primary human hepatocytes

  2021cites this paper
• Different Approaches for Nanovaccine Formulation and Characterization

  2021cites this paper
• Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection

  2021cites this paper
• Innate immunity and HBV persistence.

  2021cites this paper
• A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis

  2021cites this paper
• Immunobiology and pathogenesis of hepatitis B virus infection

  2021cites this paper
• CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance

  2021cites this paper
• A systematic study of Tupaia as a model for human acute hepatitis B infection

  2021cites this paper
• Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection

  2021cites this paper
• Hepatitis B Virus Reactivation Potentiated by Biologics.

  2020cites this paper
• HBV as a target for CAR or TCR-T cell therapy.

  2020cites this paper
• Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune‐tolerant phase

  2020cites this paper
• Role of alcohol in pathogenesis of hepatitis B virus infection

  2020cites this paper
• Hepatitis B Virus

  2020cites this paper
• An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B

  2020cites this paper
• Approximate solutions of viral dynamics in HBV infection using homotopy perturbation method

  2020cites this paper
• Role of Immune Cells in Hepatitis B Infection

  2020cites this paper
• Immune Mechanisms of Viral Clearance and Disease Pathogenesis During Viral Hepatitis

  2020cites this paper
• Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection

  2020cites this paper
• Applications of Cutting-Edge Immunoproteomics Technology in Human Immunotherapy

  2020cites this paper
• Transition to HBeAg-negative chronic hepatitis B virus infection is associated with reduced cccDNA transcriptional activity.

  2020cites this paper
• Dynamics of Immune Activation in Viral Diseases

  2020cites this paper
• Shared immunotherapeutic approaches in HIV and hepatitis B virus: combine and conquer.

  2020cites this paper
• The potential role of HLA-G in the pathogenesis of HBV infection: Immunosuppressive or immunoprotective?

  2020cites this paper
• Hepatitis B virus persistence and reactivation

  2020cites this paper
• Hepatitis C Virus

  2020cites this paper
• Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection

  2020cites this paper
• Adoptive T-cell therapy for HBV-associated HCC and HBV infection.

  2020cites this paper
• Depletion of CD8αβ+ T Cells in Chickens Demonstrates Their Involvement in Protective Immunity towards Marek’s Disease with Respect to Tumor Incidence and Vaccinal Protection

  2020cites this paper
• Investigation of Hepatitis B Serology in Oncological Patients Receiving Chemotherapy

  2020cites this paper
• Parallels between the anti-Viral State and the Irradiated State.

  2020influential citation
• Induction of Endogenous Cytokines by Traditional Chinese Medicine Leading to Reduction of Serum HBsAg Levels

  2020cites this paper
• Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis

  2020cites this paper
• Animal models for the study of human hepatitis B and D virus infection: new insights and progress.

  2020cites this paper
• Controversial: Early Innate Responses to Hepatitis B Virus Infection, an Explanation for Viral Persistence?

  2020cites this paper
• Antiviral activity of interferon‐stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter

  2020cites this paper
• Innate immune recognition and modulation in hepatitis D virus infection

  2020cites this paper
• Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection

  2020cites this paper
• Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection.

  2020cites this paper
• AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-α Production

  2020cites this paper
• Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-titer HBV Carrier Mice.

  2020cites this paper
• Immunological Analysis of the Hepatitis B Virus “a” Determinant Displayed on Chimeric Virus-Like Particles of Macrobrachium rosenbergii Nodavirus Capsid Protein Produced in Sf9 Cells

  2020cites this paper
• Photoacoustic-immune therapy with a multi-purpose black phosphorus-based nanoparticle

  2020cites this paper
• Long-term surviving influenza infected cells evade CD8+ T cell mediated clearance

  2019cites this paper
• Restoring, releasing or replacing adaptive immunity in chronic hepatitis B

  2019cites this paper
• Revisiting Hepatitis B Virus: Challenges of Curative Therapies

  2019cites this paper
• Evaluation of a Fully Human, Hepatitis B Virus-Specific Chimeric Antigen Receptor in an Immunocompetent Mouse Model.

  2019cites this paper